US stocks were largely lower on Wednesday as investors digested a hotter-than-expected January inflation reading and ...

Fourth Quarter 2024 Highlights: Revenue of $182.1 million, compared with $173.9 million in the same period last year GAAP net income of $15.0 million, or $0.26 per diluted share, compared with $21.6 ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...